Our finding, combined together, suggested that high ULK1 expression may favor the NPC cells a more aggressive phenotype, surviving form chemo/radiotherapy and metastastsizing to distant organs, suggesting a potential molecular target for NPC therapy. Here, ULK1 is linked to nasopharyngeal carcinoma.